Managing Alzheimer’s disease requires an intricate understanding of available treatments.
Michelle Sorweid, DO, MPH, sheds light on anti-amyloid antibody therapy, how it works, and what patients are good candidates. While not a cure, this therapy can decelerate disease progression for certain patients. Learn who might be eligible and why timely intervention could be key to optimizing potential benefits without exacerbating the condition.